Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul;50(7):583-5.
doi: 10.1310/hpj5007-583. Epub 2015 Jul 31.

Montelukast: Chronic Urticaria

Joyce A Generali  1 , Dennis J Cada  2
Affiliations

Montelukast: Chronic Urticaria

Joyce A Generali et al. Hosp Pharm. 2015 Jul.

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@ku.edu.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Bernstein JA, Lang DM, Khan DA, et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol. 2014;133(5):1270–1277. - PubMed
    1. Sánchez-Borges M, Asero R, Ansotegui IJ, et al.; WAO Scientific and Clinical Issues Council. Diagnosis and treatment of urticaria and angioedema: A worldwide perspective. World Allergy Organ J. 2012;5(11):125–147. - PMC - PubMed
    1. Nettis E, Colanardi MC, Paradiso MT, Ferrannini A. Desloratadine in combination with montelukast in the treatment of chronic urticaria: A randomized, double-blind, placebo-controlled study. Clin Exp Allergy. 2004;34(9):1401–1407. - PubMed
    1. Di Lorenzo G, Pacor ML, Mansueto P, et al. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol. 2004;114(3):619–625. - PubMed
    1. Wan KS. Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria. J Dermatolog Treat. 2009;20(4):194–197. - PubMed

LinkOut - more resources